RVL Pharmaceuticals plc Deferred Tax Liabilities, Net
RVL Pharmaceuticals plc had Deferred Tax Liabilities, Net of $61.00 thousand as of 2022-12-31, per its 10-K filed 2023-03-20.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net
us-gaap:DeferredTaxLiabilities · last filed 2023-03-20
- 2022-12-31: Deferred Tax Liabilities, Net $61.00K.
- 2021-12-31: Deferred Tax Liabilities, Net $151.00K.
- 2020-12-31: Deferred Tax Liabilities, Net $345.00K; Deferred Tax Liabilities, Net as first filed $344.00K.
- 2019-12-31: Deferred Tax Liabilities, Net $1.50M.
| Period end | Deferred Tax Liabilities, Net | Deferred Tax Liabilities, Net as first filed |
|---|---|---|
| 2022-12-31 | $61.00K 10-K · filed 2023-03-20 | |
| 2021-12-31 | $151.00K 10-K · filed 2023-03-20 | |
| 2020-12-31 | $345.00K 10-K · filed 2022-03-30 | $344.00K 10-K · filed 2021-03-30 |
| 2019-12-31 | $1.50M 8-K · filed 2021-09-08 | |
| 2018-12-31 | $28.29M 10-K · filed 2020-03-19 | $26.24M 10-K · filed 2019-03-28 |
| 2017-12-31 | $43.81M 8-K · filed 2019-12-20 | $42.89M 10-K · filed 2019-03-28 |